Dr. Andre Valentine Strizhak, MD

Dr. Strizhak practices at NYU Faculty Group Practice in Rego Park, New York.

Dr. Strizhak's NPI, 1447212147, was assigned on April 6, 2006. Dr. Strizhak graduated from Russian State Medical University in 1986. Dr. Strizhak holds New York license 208664.

Dr. Strizhak's primary practice is NYU Faculty Group Practice, at 97-85 Queens Blvd, Rego Park, NY 11374 in Queens County. The practice phone is (877) 648-2964.

Dr. Strizhak's primary practice is NYU Faculty Group Practice in Rego Park, New York. Dr. Strizhak is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Strizhak to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Strizhak practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Strizhak's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Strizhak is licensed in New York.

CMS data shows 816 Medicare services from Dr. Strizhak across 14 procedure codes in 2024, for 393 Medicare patients. Medicare paid $99,931 for them. Every service was in an office.

CMS counts 393 Medicare patients who saw Dr. Strizhak in 2024. The largest group is 75 to 84, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Strizhak's median patient age at 62, with 61% women.

In 2024, Dr. Strizhak wrote 676 Medicare Part D claims for 161 patients. 95% of them were for generic drugs. CMS names the drug for 588 of them, across 21 drugs with 11 or more claims each, at $19,245 in total drug cost. In 2023, CMS named 479 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Strizhak for performance year 2024, reported as part of a group. Dr. Strizhak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Dr. Strizhak from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. BIOTRONIK NRO, Inc. paid the most, $141.

Dr. Strizhak graduated from Russian State Medical University in 1986.